PLUS THERAPEUTICS, INC. (PSTV)
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
Safehold Closes Second Affordable Housing Ground Lease in Texas
Prairie Operating Co. Appoints Gregory S. Patton Chief Executive Officer and Director and Michael J. Shelly Chief Financial Officer
PHINIA Inc. to Report Q2 2026 Earnings
Wiley Raises Dividend for 33rd Consecutive Year, Powered by Research and AI Momentum, Record Margins, and Strong Cash Flow
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
Glass House Brands Announces Uplist to NYSE
DEFSEC Technologies Announces CAD$2.5 Million Registered Direct Offering
Cardiol Therapeutics Reports Results of 2026 Annual General Meeting of Shareholders
S&P Upgrades Ratings on Freedom Holding Corp. Subsidiaries to “BB-”